Clinical Trial: Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title:
Brief Summary: The aim of this study is to evaluate the safety and efficacy of iAPA-DC/CTL combined gemcitabine therapy on advanced pancreatic cancer.
Detailed Summary:
Sponsor: Changhai Hospital
Current Primary Outcome: 6-month SR [ Time Frame: 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- PFS [ Time Frame: 6 months ]progression-Free Survival
- OS [ Time Frame: 6 months ]Over survival
- ORR [ Time Frame: 2 months ]Objective Response Rate
- QOL [ Time Frame: 2 months ]Quality of Life
Original Secondary Outcome: Same as current
Information By: Changhai Hospital
Dates:
Date Received: August 18, 2015
Date Started: June 2015
Date Completion: December 2019
Last Updated: August 19, 2015
Last Verified: January 2015